» Articles » PMID: 29688086

Profile of the Alere I Influenza A & B Assay: a Pioneering Molecular Point-of-care Test

Overview
Specialty Molecular Biology
Date 2018 Apr 25
PMID 29688086
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The Alere i Influenza A & B assay incorporates the Nicking Enzyme Amplification Reaction technique on the Alere i instrument to detect and differentiate influenza virus (Flu) A and B nucleic acids in specific specimens. Areas covered: The Alere i Influenza A & B assay was cleared by the US Food and Drug Administration for use with nasal swabs (NS) and nasopharyngeal swabs, either directly or in viral transport medium. Notably, direct use on NS was the first ever CLIA-waived nucleic acid-based test. Previously published evaluations have reported sensitivities and specificities of 55.2-100% and 62.5-100% for Flu A and 45.2-100% and 53.6-100% for Flu B, respectively. Expert commentary: The Alere i Influenza A & B assay provides a rapid and simple platform for detection and differentiation of Flu A and B. Efforts are expected to further improve sensitivity and user-friendliness for effective and widespread use in the true point-of-care setting.

Citing Articles

Genosensors as an alternative diagnostic sensing approaches for specific detection of virus species: A review of common techniques and outcomes.

Babaei A, Pouremamali A, Rafiee N, Sohrabi H, Mokhtarzadeh A, de la Guardia M Trends Analyt Chem. 2022; 155:116686.

PMID: 35611316 PMC: 9119280. DOI: 10.1016/j.trac.2022.116686.


Toward a next-generation diagnostic tool: A review on emerging isothermal nucleic acid amplification techniques for the detection of SARS-CoV-2 and other infectious viruses.

Islam M, Koirala D Anal Chim Acta. 2022; 1209:339338.

PMID: 35569864 PMC: 8633689. DOI: 10.1016/j.aca.2021.339338.


Testing for Severe Acute Respiratory Syndrome-Coronavirus 2: Challenges in Getting Good Specimens, Choosing the Right Test, and Interpreting the Results.

Tu Y, OLeary T Crit Care Med. 2020; 48(11):1680-1689.

PMID: 32826428 PMC: 7467050. DOI: 10.1097/CCM.0000000000004594.


Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges.

Kilic T, Weissleder R, Lee H iScience. 2020; 23(8):101406.

PMID: 32771976 PMC: 7381402. DOI: 10.1016/j.isci.2020.101406.


Laboratory Diagnosis of COVID-19: Current Issues and Challenges.

Tang Y, Schmitz J, Persing D, Stratton C J Clin Microbiol. 2020; 58(6).

PMID: 32245835 PMC: 7269383. DOI: 10.1128/JCM.00512-20.


References
1.
Tang Y, Gonsalves S, Sun J, Stiles J, Gilhuley K, Mikhlina A . Clinical Evaluation of the Luminex NxTAG Respiratory Pathogen Panel. J Clin Microbiol. 2016; 54(7):1912-1914. PMC: 4922127. DOI: 10.1128/JCM.00482-16. View

2.
Huang S, Abe K, Bennett S, Liang T, Ladd P, Yokobe L . Disposable Autonomous Device for Swab-to-Result Diagnosis of Influenza. Anal Chem. 2017; 89(11):5776-5783. PMC: 8812334. DOI: 10.1021/acs.analchem.6b04801. View

3.
Yoon J, Yun S, Nam J, Choi S, Lim C . The use of saliva specimens for detection of influenza A and B viruses by rapid influenza diagnostic tests. J Virol Methods. 2017; 243:15-19. DOI: 10.1016/j.jviromet.2017.01.013. View

4.
Chapin K, Flores-Cortez E . Performance of the molecular Alere I influenza A&B test compared to that of the xpert flu A/B assay. J Clin Microbiol. 2014; 53(2):706-9. PMC: 4298524. DOI: 10.1128/JCM.02783-14. View

5.
OLeary M, Chappell J, Stratton C, Cronin R, Taylor M, Tang Y . Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection. J Clin Microbiol. 2010; 48(10):3803-5. PMC: 2953069. DOI: 10.1128/JCM.00825-10. View